Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

FI2P4TUM

Financiado

Cerrado

Fluorescence intraoperative imaging platform for tumor margin delineation

"According to the World Health Organization (WHO), cancer is a leading cause of death worldwide. Among the distinct types of cancer treatments, surgery, which is the oldest modality, is still often confronted with difficulties in... ver más

30/06/2013

HMGU

163K€

Presupuesto del proyecto: 163K€

Líder del proyecto

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2013-06-30 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

HMGU

0.00€ | Lider

Proyectos interesantes

PDC2021-121481-I00

Medical Technol...

Applied Physics

150K€ Cerrado

CLI

Medical Technol...

Applied Physics

2M€ Cerrado

CerISMA

Medical Technol...

Data Science

2M€ Cerrado

CoDaFlight

Medical Technol...

Applied Physics

3M€ Cerrado

CoDaFlight

Medical Technol...

Applied Physics

3M€ Cerrado

FLUODIAMON

Medical Technol...

Applied Physics

6M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 163K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "According to the World Health Organization (WHO), cancer is a leading cause of death worldwide. Among the distinct types of cancer treatments, surgery, which is the oldest modality, is still often confronted with difficulties in the identification of cancer spread and the accurate delineation of tumor margins. This is of uttermost importance in order to infer the lowest harm to the organ where the tumor originated but without leaving residual tumor. This proposal is intended to improve the surgical outcome, employing a highly sensitive fluorescence imaging approach, which holds a strong potential to become a key technology in intraoperative imaging. The primary goal is to employ real‐time multi‐spectral fluorescence imaging for sensitive and quantitative molecular visualization of infiltrating cancer, which can enable real‐time surgical feedback and improved surgical outcome over the current state of the art and clinical practice. For this goal an advanced multi‐spectral fluorescence imaging system that can significantly improve quantification and the observation accuracy over simple fluorescence video systems considered in the past, will be developed. Further promising new fluorescence probes will be utilized and their ability to offer high detection sensitivity and specificity of tumor margins will be investigated. The performance of this approach will be examined in controlled phantoms and in‐vivo in breast cancer and abdominal cancer in animal models. Moreover, the method will be examined in relation to offering real‐time pathology of lymph‐nodes in‐vivo. If this proposal is successful, it will lead to the development of an accurate imaging platform that can enhance surgical vision while seamlessly integrating in the operating surgical room. Due to the direct relation of the surgeon’s vision to optical methods and the relatively low cost and non‐ionizing energies used, a high dissemination potential into the surgical healthcare is expected."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores